234 related articles for article (PubMed ID: 33445954)
41. The pharmacogenetics of analgesia.
Stamer UM; Stüber F
Expert Opin Pharmacother; 2007 Oct; 8(14):2235-45. PubMed ID: 17927480
[TBL] [Abstract][Full Text] [Related]
42. Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.
Nielsen LM; Christrup LL; Sato H; Drewes AM; Olesen AE
Basic Clin Pharmacol Toxicol; 2017 Jul; 121(1):6-12. PubMed ID: 28084056
[TBL] [Abstract][Full Text] [Related]
43. Opioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapy.
Rosendo LM; Rosado T; Zandonai T; Rincon K; Peiró AM; Barroso M; Gallardo E
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892112
[TBL] [Abstract][Full Text] [Related]
44. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
45. Codeine and opioid metabolism: implications and alternatives for pediatric pain management.
Chidambaran V; Sadhasivam S; Mahmoud M
Curr Opin Anaesthesiol; 2017 Jun; 30(3):349-356. PubMed ID: 28323671
[TBL] [Abstract][Full Text] [Related]
46. Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease.
Mapira NL; Thelingwani RS; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 May; 24(7):359-369. PubMed ID: 37248824
[No Abstract] [Full Text] [Related]
47. Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.
Mosley SA; Hicks JK; Portman DG; Donovan KA; Gopalan P; Schmit J; Starr J; Silver N; Gong Y; Langaee T; Clare-Salzler M; Starostik P; Chang YD; Rajasekhara S; Smith JE; Soares HP; George TJ; McLeod HL; Cavallari LH
Contemp Clin Trials; 2018 May; 68():7-13. PubMed ID: 29535047
[TBL] [Abstract][Full Text] [Related]
48. Gender based differences, pharmacogenetics and adverse events in chronic pain management.
Planelles B; Margarit C; Inda MD; Ballester P; Muriel J; Barrachina J; Ajo R; Esteban MD; Peiró AM
Pharmacogenomics J; 2020 Apr; 20(2):320-328. PubMed ID: 31745220
[TBL] [Abstract][Full Text] [Related]
49. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans.
Mogil JS; Ritchie J; Smith SB; Strasburg K; Kaplan L; Wallace MR; Romberg RR; Bijl H; Sarton EY; Fillingim RB; Dahan A
J Med Genet; 2005 Jul; 42(7):583-7. PubMed ID: 15994880
[TBL] [Abstract][Full Text] [Related]
50. Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.
Jannetto PJ; Bratanow NC
Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):745-52. PubMed ID: 21585291
[TBL] [Abstract][Full Text] [Related]
51. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence.
Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A
PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466
[TBL] [Abstract][Full Text] [Related]
52. Genomics testing and personalized medicine in the preoperative setting: Can it change outcomes in postoperative pain management?
Chaturvedi R; Alexander B; A'Court AM; Waterman RS; Burton BN; Urman RD; Gabriel RA
Best Pract Res Clin Anaesthesiol; 2020 Jun; 34(2):283-295. PubMed ID: 32711834
[TBL] [Abstract][Full Text] [Related]
53. Engaging pharmacogenomics in pain management and opioid selection.
Bright DR; Petry N; Roath E; Gibb T
Pharmacogenomics; 2021 Sep; 22(14):927-937. PubMed ID: 34521258
[TBL] [Abstract][Full Text] [Related]
54. OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients.
Muriel J; Margarit C; Planelles B; Serralta MJ; Puga C; Inda MD; Cutillas E; Morales D; Horga JF; Peiró AM
Ann N Y Acad Sci; 2018 Aug; 1425(1):82-93. PubMed ID: 29781244
[TBL] [Abstract][Full Text] [Related]
55. Lost in translation? Learning from the opioid epidemic in the USA.
Weisberg D; Stannard C
Anaesthesia; 2013 Dec; 68(12):1215-9. PubMed ID: 24219250
[No Abstract] [Full Text] [Related]
56. A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy.
Lewandrowski KU; Sharafshah A; Elfar J; Schmidt SL; Blum K; Wetzel FT
Cell Mol Neurobiol; 2024 May; 44(1):47. PubMed ID: 38801645
[TBL] [Abstract][Full Text] [Related]
57. Pharmacogenetics in obstetric anesthesia.
Landau R; Kraft JC
Curr Opin Anaesthesiol; 2010 Jun; 23(3):323-9. PubMed ID: 20440109
[TBL] [Abstract][Full Text] [Related]
58. Pharmacogenomics of methadone: a narrative review of the literature.
Packiasabapathy S; Aruldhas BW; Horn N; Overholser BR; Quinney SK; Renschler JS; Sadhasivam S
Pharmacogenomics; 2020 Aug; 21(12):871-887. PubMed ID: 32705966
[No Abstract] [Full Text] [Related]
59. Review of perioperative pain management of opioid-dependent patients.
Vadivelu N; Mitra S; Kai AM; Kodumudi G; Gritsenko K
J Opioid Manag; 2016; 12(4):289-301. PubMed ID: 27575830
[TBL] [Abstract][Full Text] [Related]
60. Is there genetic polymorphism evidence for individual human sensitivity to opiates?
Nagashima M; Katoh R; Sato Y; Tagami M; Kasai S; Ikeda K
Curr Pain Headache Rep; 2007 Apr; 11(2):115-23. PubMed ID: 17367590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
